Merck KGaA (MKKGY) Projected to Post Earnings on Thursday

Key Points

• Merck KGaA is anticipated to announce its quarterly earnings on Thursday, August 7th, with analysts expecting earnings of $0.48 per share and revenue of $5.34 billion.
• In its last earnings report on May 15th, Merck KGaA exceeded expectations with earnings of $0.59 per share and revenue of $5.89 billion, outperforming estimates.
• Shares of Merck KGaA are currently trading at $25.49, having a market capitalization of $16.47 billion and a price-to-earnings ratio of 12.07.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Thursday, August 7th. Analysts expect the company to announce earnings of $0.48 per share and revenue of $5.34 billion for the quarter.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.59 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.09. The business had revenue of $5.89 billion for the quarter, compared to analysts' expectations of $5.32 billion. Merck KGaA had a net margin of 13.23% and a return on equity of 9.61%. On average, analysts expect Merck KGaA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Merck KGaA Price Performance

Shares of OTCMKTS MKKGY traded down $0.06 during midday trading on Friday, reaching $24.96. 211,878 shares of the company traded hands, compared to its average volume of 127,024. The firm has a market cap of $16.13 billion, a PE ratio of 11.82, a PEG ratio of 1.98 and a beta of 0.91. The stock's 50-day simple moving average is $26.09 and its 200-day simple moving average is $27.41. Merck KGaA has a 12 month low of $24.32 and a 12 month high of $39.17. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.83 and a current ratio of 1.31.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.